At a glance
ClinicalIndex Comparison RecordN/ACompleted· 50 enrolled
Drug / intervention
Indocyanine green solution +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Testing the Efficacy of Indocyanine Green Imaging (ICG-SPY) in the Identification of Sentinel Lymph Nodes (SLN) in Patients With Malignant Melanoma
In Brief
A clinical study evaluating Indocyanine green solution, Isosulfan blue (ISB), and 1 other intervention for Recurrent Melanoma. Completed, enrolled 50 participants across 1 site.
Detailed Summary
This clinical trial compares and contrasts lymph node mapping using indocyanine green (IC-GREEN), isosulfan blue (ISB), and TSC and Lymphoscintigraphy with 99-technetium (99Tc) sulfur colloid (TSC). Study participants with malignant melanoma will undergo all 3 evaluations to assess the extent of the spread of the melanoma.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsRecurrent Melanoma
CountriesUnited States
CollaboratorsNational Cancer Institute (NCI)
Timeline
N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
Enrollment StartJun 2013
First PostedJul 2013
Primary CompletionJun 2014
Study CompletionApr 2015
TodayJul 2026
First PostedJul 12, 2013
Enrollment StartJun 1, 2013
Primary CompletionJun 1, 2014
Study CompletionApr 1, 2015
TodayJul 2, 2026
Enrollment to primary: 1 yearPosted 13.0 years ago
Interventions
Indocyanine green solutiondrug
Administered peri-tumoral and intradermally
Isosulfan blue (ISB)drug
Administered peri-tumoral and intradermally
Lymphoscintigraphy with 99-technetium (99Tc) sulfur colloid (TSC)other